Skip to main content
v2026.11,772 entries · CC-BY 4.0

Lab Data Management Software: A Procurement and Evaluation Guide

A buying guide to lab data management software (LIMS, ELN, SDMS, sample trackers): what the category covers, the compliance frameworks that shape the decision (ALCOA+, 21 CFR Part 11, ISO/IEC 17025, computer system validation), and a defensible vendor evaluation and procurement process.

Ask CASRAI · included with Regulatory Radar

Ask about Lab Data Management Software: A Procurement and Evaluation Guide

Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.

150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Written and maintained by CASRAI Editorial Board

Last updated

“Lab data management software” is an umbrella term, not a single product category. When a procurement officer, lab manager, or research administrator goes looking for it, they usually land on one of several distinct systems — a Laboratory Information Management System (LIMS), an Electronic Lab Notebook (ELN), a Scientific Data Management System (SDMS), or a narrower sample/inventory tracker — each solving a different part of the same problem: capturing, organizing, and preserving the data a lab generates so it can be trusted, audited, and reused. This guide covers how to evaluate lab data management software as a purchasing decision: what the category actually includes, what accreditation and regulatory frameworks bear on the choice, and what a defensible evaluation and procurement process looks like.

What counts as “lab data management software”

In practice, the term covers overlapping but distinct system types. Buying the wrong one — or buying several that don’t talk to each other — is the most common procurement mistake in this category.

  • LIMS (Laboratory Information Management System): manages samples, workflows, and results — sample accessioning, chain of custody, test assignment, results reporting, and (in accredited labs) the records an ISO/IEC 17025 or CLIA inspection will ask for. See What Is a LIMS?
  • ELN (Electronic Lab Notebook): the digital replacement for the paper notebook — experiment records, protocols, observations, and (for regulated or IP-sensitive work) a timestamped, signed record of who did what and when.
  • SDMS (Scientific Data Management System): captures and archives raw instrument output (chromatography, spectroscopy, imaging files) directly off the instrument, independent of whether a LIMS or ELN is also in use — the layer most labs discover they’re missing only after an audit asks where the raw data behind a reported result actually lives.
  • Sample/inventory trackers: lighter-weight tools scoped to sample or reagent inventory alone, without full LIMS workflow or compliance functionality.

Many labs need more than one of these, integrated. A useful first procurement question is not “which lab data management software should we buy” but “which of these problems do we actually have, and does closing that gap require a new system or a missing integration between systems we already have.” For a structured side-by-side of the category options, see Laboratory Management Software: LIMS vs ELN vs LIS vs Scheduling Systems and LIMS vs ELN: What’s the Difference?.

Why the buying decision is higher-stakes than ordinary software procurement

Lab data management software sits underneath every result a lab reports. If the lab operates under any accreditation, certification, or regulatory framework, the software itself becomes part of what gets audited — not just a productivity tool. That changes the evaluation criteria in ways generic IT procurement checklists don’t capture.

Data integrity (ALCOA+)

Regulators and accreditors assess electronic records against the ALCOA+ framework — data should be Attributable, Legible, Contemporaneous, Original, and Accurate, plus Complete, Consistent, Enduring, and Available. This originated in FDA data-integrity guidance and was formalized as the nine-attribute “ALCOA+” set by the UK’s MHRA. In a procurement context, this translates into concrete software requirements: a tamper-evident audit trail on every record, no ability to silently overwrite prior entries, timestamps tied to actual entry time, and durable, retrievable storage across the retention period your accreditation or regulator requires.

21 CFR Part 11 (electronic records and signatures)

If any of the lab’s work is FDA-regulated (GxP, clinical, or submission-supporting data), the software needs to support FDA’s 21 CFR Part 11 requirements for electronic records and electronic signatures — access controls, unique user credentials, audit trails, and validated system controls. Even labs outside direct FDA jurisdiction increasingly adopt Part 11-aligned controls because it’s the closest thing to an industry-standard bar for defensible electronic records.

Computer system validation

In GxP environments, the software itself must be validated before it’s trusted for regulated work — documented Installation, Operational, and Performance Qualification (IQ/OQ/PQ), typically scoped using a risk-based framework such as GAMP 5. This is a real procurement cost: ask any vendor being evaluated for GxP use what validation documentation (IQ/OQ protocols, vendor audit reports, a validation master plan template) they provide out of the box versus what your team has to build from scratch. See Computer System Validation: GAMP 5, IQ/OQ/PQ, and 21 CFR Part 11 for the full validation lifecycle.

Accreditation support

Labs accredited to ISO/IEC 17025 or operating under CLIA need software that can produce the specific records an assessor asks for: calibration and maintenance history tied to results, traceable chain of custody, method version control, and reportable-range/uncertainty documentation where applicable. Ask a vendor directly whether their system has been used successfully through an actual accreditation cycle at a comparable lab, not just whether it “supports compliance” in marketing language.

Evaluation criteria for a procurement decision

Beyond the compliance layer above, a structured evaluation should weigh these dimensions explicitly, ideally scored against your own lab’s actual workflow rather than a generic feature checklist:

  • Instrument and system integration: can it pull data directly from your instruments (via vendor drivers, ASTM/HL7 interfaces for clinical LIS connections, or file-based import), or does it require manual re-entry that introduces transcription risk?
  • Deployment model: cloud/SaaS, on-premises, or hybrid — each has different implications for validation burden, IT overhead, data residency, and uptime dependency. A cloud vendor’s own SOC 2 report or equivalent third-party audit is a reasonable thing to ask for during evaluation.
  • Data ownership and exit terms: can you export your full dataset, in a usable, non-proprietary format, if you switch vendors later? This should be a contract term, not an assumption — migration lock-in is one of the most common regrets labs report after switching systems.
  • Audit trail and access control granularity: role-based permissions, and an audit trail that logs who changed what, when, without requiring an add-on module.
  • Scalability: whether the system’s pricing and architecture hold up as sample volume, user count, or the number of connected instruments grows, without a disruptive re-platforming later.
  • Vendor support and longevity: response-time commitments (an SLA, not a promise), release/patch cadence, and evidence the vendor will still be supporting the product in five years — relevant given how long validated systems typically stay in place once qualified.
  • Total cost of ownership: license/subscription cost is the visible number; validation labor, integration work, training, and ongoing administration are usually the larger real cost over the system’s life.

A procurement process that holds up to audit

The same structured, documented approach used for lab equipment and reagent procurement applies to software: a documented decision trail protects the lab if a regulator or accreditor later asks why a system was selected.

  1. Write a requirements specification first. Capture regulatory/accreditation requirements, integration needs, and user workflow requirements before looking at any vendor — this keeps the evaluation objective rather than reverse-engineered from whichever demo looked best.
  2. Run a structured vendor evaluation. Score candidates against your own written requirements, not a vendor-supplied comparison. See Vendor Qualification Process for a general framework, and request references from labs of comparable size, discipline, and accreditation scope — not just the vendor’s flagship customer.
  3. Pilot before committing. A limited proof-of-concept with real (or realistic de-identified) data surfaces integration and workflow problems a demo won’t.
  4. Audit the vendor, not just the product. For GxP or accredited-lab use, a supplier audit covering the vendor’s own quality system, security practices, and (for cloud deployments) subprocessor and data-handling practices is standard due diligence. See Supplier Audit: Types, Process, and a Checklist.
  5. Plan validation and training as part of the project, not an afterthought. Budget the IQ/OQ/PQ work, SOP updates, and user training into the implementation timeline and cost, not as a post-go-live scramble.
  6. Set a review cadence. Re-evaluate fit against evolving accreditation requirements, instrument fleet changes, and vendor performance on a fixed schedule rather than only when something breaks.

Procurement teams sourcing lab data management systems alongside other lab supplies and equipment may already work through a distributor or group purchasing arrangement for hardware and consumables — for example, medical and lab supply distributors such as LAC Health operate in that broader lab-procurement space. The evaluation criteria in this guide apply the same way regardless of how the software itself is sourced or licensed: the compliance and integration questions above matter more than the purchasing channel.

Common mistakes to avoid

  • Buying features instead of solving the workflow gap. A long feature list doesn’t guarantee the system fits how your lab actually accessions samples, runs methods, or reports results.
  • Skipping validation planning until after purchase. Validation is frequently the largest real cost of a GxP system deployment; pricing it in during evaluation avoids a mid-project budget surprise.
  • Assuming “cloud” and “validated” are automatically compatible. Cloud/SaaS systems can absolutely be validated and Part 11-compliant, but that depends on the vendor’s change-control practices and your own validation approach to a system you don’t host — confirm this explicitly rather than assuming it.
  • No exit plan. Data portability terms negotiated at signing are far easier to get than data portability negotiated after a vendor relationship has soured.

Frequently asked questions

Is lab data management software the same thing as a LIMS?

No. A LIMS is one specific type of lab data management software, focused on sample and workflow management. “Lab data management software” is the broader category that also includes ELNs, SDMS platforms, and inventory/sample trackers — a lab may need one, several, or an integrated combination.

Does lab data management software need to be validated?

Only if it’s used to generate, process, or store records supporting GxP-regulated work (or another framework with a validation requirement). Research-only or non-regulated lab use doesn’t carry the same formal IQ/OQ/PQ obligation, though the data-integrity principles (audit trail, access control) remain good practice regardless.

What’s the difference between cloud and on-premises deployment for compliance purposes?

Both can be made compliant, but the burden shifts: on-premises deployments put validation and infrastructure control fully in your hands, while cloud/SaaS deployments require confirming the vendor’s own controls (change management, security audits, subprocessor practices) meet your compliance obligations, since you don’t control the underlying infrastructure directly.

How long does implementation and validation typically take?

This varies widely by system scope, integration complexity, and validation rigor required — ask each vendor for a realistic timeline based on comparable prior deployments rather than relying on a generic industry estimate, since the range across LIMS/ELN/SDMS implementations is genuinely wide.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 72,264 indexed passages, and every answer cites the ones it drew on.